<?xml version="1.0" encoding="UTF-8"?>
<ASSEMBLY_SET>
<ASSEMBLY accession="GCA_000986055.1" alias="A/England/8/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986055.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/8/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/8/2010 assembly for Influenza A virus (A/England/8/2009(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/8/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645787</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/8/2009(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/8/2009</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3293238</PRIMARY_ID>
      <SECONDARY_ID>ERS671537</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN845779.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN845780.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN845781.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN845782.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN845783.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN845784.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN845785.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN845786.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986055.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986075.1" alias="A/England/12/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986075.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/12/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/12/2010 assembly for Influenza A virus (A/England/12/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/12/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645777</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/12/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/12/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295933</PRIMARY_ID>
      <SECONDARY_ID>ERS671535</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN845771.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN845772.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN845773.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN845774.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN845775.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN845776.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN845777.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN845778.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986075.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986095.1" alias="A/England/251/2011" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986095.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/251/2011</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/251/2011 assembly for Influenza A virus (A/England/251/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/251/2011</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645788</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/251/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/251/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3298783</PRIMARY_ID>
      <SECONDARY_ID>ERS671538</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN845787.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN845788.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN845789.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN845790.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN845791.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN845792.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN845793.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN845794.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986095.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986115.1" alias="A/England/05120003/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986115.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/05120003/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/05120003/2010 assembly for Influenza A virus (A/England/05120003/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/05120003/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645851</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/05120003/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/05120003/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295967</PRIMARY_ID>
      <SECONDARY_ID>ERS671555</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846372.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846373.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846374.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846375.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846376.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846377.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846378.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846379.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986115.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986135.1" alias="A/England/697/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986135.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/697/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/697/2010 assembly for Influenza A virus (A/England/697/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/697/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645807</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/697/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/697/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294265</PRIMARY_ID>
      <SECONDARY_ID>ERS671592</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846523.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846524.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846525.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846526.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846527.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846528.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846529.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846530.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986135.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986155.1" alias="A/England/01180016/2009" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986155.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/01180016/2009</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/01180016/2009 assembly for Influenza A virus (A/England/01180016/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/01180016/2009</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645866</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/01180016/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/01180016/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295978</PRIMARY_ID>
      <SECONDARY_ID>ERS671585</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846507.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846508.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846509.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846510.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846511.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846512.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846513.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846514.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986155.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13136</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13136</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986175.1" alias="A/England/10740707/2011" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986175.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/10740707/2011</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/10740707/2011 assembly for Influenza A virus (A/England/10740707/2011(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/10740707/2011</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645799</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/10740707/2011(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/10740707/2011</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299098</PRIMARY_ID>
      <SECONDARY_ID>ERS671575</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846451.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846452.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846453.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846454.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846455.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846456.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846457.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846458.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986175.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986195.1" alias="A/England/05040138/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986195.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/05040138/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/05040138/2010 assembly for Influenza A virus (A/England/05040138/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/05040138/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645854</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/05040138/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/05040138/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299087</PRIMARY_ID>
      <SECONDARY_ID>ERS671558</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846427.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846428.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846429.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846430.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846431.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846432.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846433.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846434.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986195.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986215.1" alias="A/England/05100298/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986215.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/05100298/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/05100298/2010 assembly for Influenza A virus (A/England/05100298/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/05100298/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645845</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/05100298/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/05100298/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295937</PRIMARY_ID>
      <SECONDARY_ID>ERS671543</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846341.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846342.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846343.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846344.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846345.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846346.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846347.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846348.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986215.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986235.1" alias="A/England/01220736/2009" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986235.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/01220736/2009</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/01220736/2009 assembly for Influenza A virus (A/England/01220736/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/01220736/2009</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645864</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/01220736/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/01220736/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299516</PRIMARY_ID>
      <SECONDARY_ID>ERS671583</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846491.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846492.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846493.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846494.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846495.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846496.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846497.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846498.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986235.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986255.1" alias="A/England/676/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986255.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/676/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/676/2010 assembly for Influenza A virus (A/England/676/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/676/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645802</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/676/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/676/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3293241</PRIMARY_ID>
      <SECONDARY_ID>ERS671580</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846475.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846476.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846477.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846478.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846479.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846480.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846481.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846482.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986255.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986275.1" alias="A/England/446/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986275.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/446/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/446/2010 assembly for Influenza A virus (A/England/446/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/446/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645790</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/446/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/446/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3298788</PRIMARY_ID>
      <SECONDARY_ID>ERS671549</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846356.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846357.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846358.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846359.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846360.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846361.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846362.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846363.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986275.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986295.1" alias="A/England/245/2011" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986295.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/245/2011</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/245/2011 assembly for Influenza A virus (A/England/245/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/245/2011</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645865</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/245/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/245/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295977</PRIMARY_ID>
      <SECONDARY_ID>ERS671584</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846499.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846500.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846501.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846502.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846503.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846504.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846505.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846506.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986295.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986315.1" alias="A/England/WTSI1832/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986315.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/WTSI1832/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/WTSI1832/2010 assembly for Influenza A virus (A/England/WTSI1832/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/WTSI1832/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645877</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/WTSI1832/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/WTSI1832/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299522</PRIMARY_ID>
      <SECONDARY_ID>ERS671607</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846579.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846580.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846581.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846582.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846583.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846584.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846585.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846586.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986315.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986335.1" alias="A/England/675/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986335.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/675/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/675/2010 assembly for Influenza A virus (A/England/675/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/675/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645844</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/675/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/675/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295936</PRIMARY_ID>
      <SECONDARY_ID>ERS671542</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846333.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846334.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846335.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846336.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846337.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846338.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846339.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846340.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986335.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986355.1" alias="A/England/701/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986355.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/701/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/701/2010 assembly for Influenza A virus (A/England/701/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/701/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645803</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/701/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/701/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299514</PRIMARY_ID>
      <SECONDARY_ID>ERS671581</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846483.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846484.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846485.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846486.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846487.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846488.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846489.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846490.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986355.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986375.1" alias="A/England/331/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986375.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/331/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/331/2010 assembly for Influenza A virus (A/England/331/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/331/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645782</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/331/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/331/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3293243</PRIMARY_ID>
      <SECONDARY_ID>ERS671595</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846539.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846540.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846541.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846542.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846543.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846544.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846545.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846546.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986375.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986395.1" alias="A/England/WTSI1778/2009" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986395.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/WTSI1778/2009</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/WTSI1778/2009 assembly for Influenza A virus (A/England/WTSI1778/2009(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/WTSI1778/2009</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645792</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/WTSI1778/2009(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/WTSI1778/2009</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299085</PRIMARY_ID>
      <SECONDARY_ID>ERS671554</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846364.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846365.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846366.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846367.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846368.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846369.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846370.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846371.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986395.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986415.1" alias="A/England/WTSI1822/2011" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986415.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/WTSI1822/2011</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/WTSI1822/2011 assembly for Influenza A virus (A/England/WTSI1822/2011(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/WTSI1822/2011</NAME>
  <ASSEMBLY_LEVEL>chromosome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645808</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/WTSI1822/2011(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/WTSI1822/2011</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3293245</PRIMARY_ID>
      <SECONDARY_ID>ERS671597</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846555.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846556.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846557.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846558.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846559.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846560.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846561.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846562.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986415.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13123</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>9</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>1</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986435.1" alias="A/England/10820742/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986435.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/10820742/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/10820742/2010 assembly for Influenza A virus (A/England/10820742/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/10820742/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645869</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/10820742/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/10820742/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294261</PRIMARY_ID>
      <SECONDARY_ID>ERS671588</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846515.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846516.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846517.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846518.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846519.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846520.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846521.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846522.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986435.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986455.1" alias="A/England/10740571/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986455.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/10740571/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/10740571/2010 assembly for Influenza A virus (A/England/10740571/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/10740571/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645776</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/10740571/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/10740571/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294270</PRIMARY_ID>
      <SECONDARY_ID>ERS671605</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846571.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846572.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846573.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846574.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846575.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846576.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846577.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846578.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986455.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986475.1" alias="A/England/05020665/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986475.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/05020665/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/05020665/2010 assembly for Influenza A virus (A/England/05020665/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/05020665/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645798</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/05020665/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/05020665/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299097</PRIMARY_ID>
      <SECONDARY_ID>ERS671574</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846443.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846444.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846445.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846446.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846447.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846448.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846449.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846450.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986475.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986495.1" alias="A/England/671/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986495.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/671/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/671/2010 assembly for Influenza A virus (A/England/671/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/671/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645800</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/671/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/671/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3293240</PRIMARY_ID>
      <SECONDARY_ID>ERS671576</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846459.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846460.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846461.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846462.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846463.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846464.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846465.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846466.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986495.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986515.1" alias="A/England/9/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986515.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/9/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/9/2010 assembly for Influenza A virus (A/England/9/2009(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/9/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645783</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/9/2009(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/9/2009</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3293244</PRIMARY_ID>
      <SECONDARY_ID>ERS671596</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846547.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846548.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846549.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846550.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846551.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846552.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846553.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846554.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986515.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986535.1" alias="A/England/10740579/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986535.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/10740579/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/10740579/2010 assembly for Influenza A virus (A/England/10740579/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/10740579/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645801</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/10740579/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/10740579/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295976</PRIMARY_ID>
      <SECONDARY_ID>ERS671579</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846467.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846468.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846469.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846470.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846471.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846472.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846473.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846474.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986535.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986555.1" alias="A/England/32/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986555.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/32/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/32/2010 assembly for Influenza A virus (A/England/32/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/32/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645796</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/32/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/32/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299095</PRIMARY_ID>
      <SECONDARY_ID>ERS671569</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846435.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846436.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846437.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846438.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846439.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846440.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846441.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846442.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986555.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986575.1" alias="A/England/00380719/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986575.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/00380719/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/00380719/2010 assembly for Influenza A virus (A/England/00380719/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/00380719/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645871</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/00380719/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/00380719/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3293242</PRIMARY_ID>
      <SECONDARY_ID>ERS671594</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846531.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846532.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846533.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846534.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846535.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846536.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846537.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846538.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986575.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986595.1" alias="A/England/00380718/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986595.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/00380718/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/00380718/2010 assembly for Influenza A virus (A/England/00380718/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/00380718/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645883</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/00380718/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/00380718/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294272</PRIMARY_ID>
      <SECONDARY_ID>ERS671617</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846587.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846588.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846589.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846590.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846591.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846592.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846593.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846594.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986595.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13136</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13136</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_000986615.1" alias="A/England/673/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_000986615.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/673/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/673/2010 assembly for Influenza A virus (A/England/673/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/673/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645810</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/673/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/673/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299518</PRIMARY_ID>
      <SECONDARY_ID>ERS671602</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846563.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846564.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846565.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846566.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846567.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846568.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846569.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846570.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_000/GCA_000986/GCA_000986615.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001006685.1" alias="A/England/719/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001006685.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/719/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/719/2010 assembly for Influenza A virus (A/England/719/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/719/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645826</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/719/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/719/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299976</PRIMARY_ID>
      <SECONDARY_ID>ERS671631</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846668.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846669.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846670.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846671.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846672.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846673.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846674.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846675.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001006/GCA_001006685.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-14</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001006725.1" alias="A/England/10/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001006725.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/10/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/10/2010 assembly for Influenza A virus (A/England/10/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/10/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645830</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/10/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/10/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299980</PRIMARY_ID>
      <SECONDARY_ID>ERS671638</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846784.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846785.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846786.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846787.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846788.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846789.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846790.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846791.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001006/GCA_001006725.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-14</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001006745.1" alias="A/England/10740685/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001006745.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/10740685/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/10740685/2010 assembly for Influenza A virus (A/England/10740685/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/10740685/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645841</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/10740685/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/10740685/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294445</PRIMARY_ID>
      <SECONDARY_ID>ERS671658</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846792.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846793.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846794.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846795.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846796.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846797.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846798.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846799.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001006/GCA_001006745.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001006825.1" alias="A/England/343/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001006825.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/343/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/343/2010 assembly for Influenza A virus (A/England/343/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/343/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645846</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/343/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/343/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295964</PRIMARY_ID>
      <SECONDARY_ID>ERS671544</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846620.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846621.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846622.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846623.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846624.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846625.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846626.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846627.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001006/GCA_001006825.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-14</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001006845.1" alias="A/England/677/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001006845.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/677/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/677/2010 assembly for Influenza A virus (A/England/677/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/677/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645823</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/677/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/677/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294437</PRIMARY_ID>
      <SECONDARY_ID>ERS671627</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846644.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846645.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846646.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846647.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846648.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846649.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846650.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846651.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001006/GCA_001006845.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001006865.1" alias="A/England/10740704/2011" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001006865.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/10740704/2011</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/10740704/2011 assembly for Influenza A virus (A/England/10740704/2011(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/10740704/2011</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645819</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/10740704/2011(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/10740704/2011</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294277</PRIMARY_ID>
      <SECONDARY_ID>ERS671623</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846636.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846637.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846638.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846639.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846640.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846641.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846642.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846643.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001006/GCA_001006865.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-14</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001006885.1" alias="A/England/WTSI1781/2011" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001006885.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/WTSI1781/2011</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/WTSI1781/2011 assembly for Influenza A virus (A/England/WTSI1781/2011(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/WTSI1781/2011</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645853</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/WTSI1781/2011(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/WTSI1781/2011</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299086</PRIMARY_ID>
      <SECONDARY_ID>ERS671557</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846628.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846629.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846630.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846631.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846632.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846633.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846634.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846635.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001006/GCA_001006885.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-14</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001006905.1" alias="A/England/05160420/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001006905.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/05160420/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/05160420/2010 assembly for Influenza A virus (A/England/05160420/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/05160420/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645825</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/05160420/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/05160420/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299529</PRIMARY_ID>
      <SECONDARY_ID>ERS671629</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846652.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846653.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846654.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846655.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846656.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846657.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846658.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846659.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001006/GCA_001006905.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-14</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001006925.1" alias="A/England/WTSI2051/2011" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001006925.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/WTSI2051/2011</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/WTSI2051/2011 assembly for Influenza A virus (A/England/WTSI2051/2011(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/WTSI2051/2011</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645885</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/WTSI2051/2011(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/WTSI2051/2011</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299975</PRIMARY_ID>
      <SECONDARY_ID>ERS671630</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN846660.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846661.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846662.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846663.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846664.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846665.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846666.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN846667.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001006/GCA_001006925.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-14</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001013605.1" alias="A/England/29/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001013605.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/29/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/29/2010 assembly for Influenza A virus (A/England/29/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/29/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645784</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/29/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/29/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3298780</PRIMARY_ID>
      <SECONDARY_ID>ERS671531</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850027.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850028.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850029.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850030.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850031.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850032.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850033.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850034.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001013/GCA_001013605.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001013625.1" alias="A/England/468/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001013625.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/468/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/468/2010 assembly for Influenza A virus (A/England/468/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/468/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645786</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/468/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/468/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295932</PRIMARY_ID>
      <SECONDARY_ID>ERS671533</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850043.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850044.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850045.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850046.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850047.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850048.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850049.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850050.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001013/GCA_001013625.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001013645.1" alias="A/England/05020662/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001013645.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/05020662/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/05020662/2010 assembly for Influenza A virus (A/England/05020662/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/05020662/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645795</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/05020662/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/05020662/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299089</PRIMARY_ID>
      <SECONDARY_ID>ERS671563</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850083.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850084.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850085.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850086.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850087.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850088.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850089.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850090.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001013/GCA_001013645.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001013665.1" alias="A/England/10740571/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001013665.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/10740571/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/10740571/2010 assembly for Influenza A virus (A/England/10740571/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/10740571/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645776</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/10740571/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/10740571/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3298774</PRIMARY_ID>
      <SECONDARY_ID>ERS671490</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN849987.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN849988.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN849989.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN849990.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN849991.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN849992.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN849993.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN849994.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001013/GCA_001013665.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001013685.1" alias="A/England/00380710/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001013685.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/00380710/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/00380710/2010 assembly for Influenza A virus (A/England/00380710/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/00380710/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645794</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/00380710/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/00380710/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295971</PRIMARY_ID>
      <SECONDARY_ID>ERS671562</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850075.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850076.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850077.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850078.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850079.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850080.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850081.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850082.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001013/GCA_001013685.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001013705.1" alias="A/England/WTSI1807/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001013705.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/WTSI1807/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/WTSI1807/2010 assembly for Influenza A virus (A/England/WTSI1807/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/WTSI1807/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645804</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/WTSI1807/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/WTSI1807/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299515</PRIMARY_ID>
      <SECONDARY_ID>ERS671582</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850099.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850100.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850101.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850102.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850103.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850104.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850105.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850106.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001013/GCA_001013705.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001013725.1" alias="A/England/11/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001013725.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/11/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/11/2010 assembly for Influenza A virus (A/England/11/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/11/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645805</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/11/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/11/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294263</PRIMARY_ID>
      <SECONDARY_ID>ERS671590</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850122.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850123.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850124.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850125.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850126.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850127.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850128.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850129.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001013/GCA_001013725.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001013745.1" alias="A/England/WTSI1769/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001013745.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/WTSI1769/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/WTSI1769/2010 assembly for Influenza A virus (A/England/WTSI1769/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/WTSI1769/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645781</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/WTSI1769/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/WTSI1769/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3298786</PRIMARY_ID>
      <SECONDARY_ID>ERS671545</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850019.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850020.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850021.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850022.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850023.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850024.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850025.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850026.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001013/GCA_001013745.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2016-12-16</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001013765.1" alias="A/England/10740664/2011" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001013765.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/10740664/2011</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/10740664/2011 assembly for Influenza A virus (A/England/10740664/2011(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/10740664/2011</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645780</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/10740664/2011(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/10740664/2011</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295935</PRIMARY_ID>
      <SECONDARY_ID>ERS671540</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850011.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850012.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850013.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850014.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850015.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850016.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850017.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850018.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001013/GCA_001013765.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001013785.1" alias="A/England/21680633/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001013785.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/21680633/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/21680633/2010 assembly for Influenza A virus (A/England/21680633/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/21680633/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645806</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/21680633/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/21680633/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294264</PRIMARY_ID>
      <SECONDARY_ID>ERS671591</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850130.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850131.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850132.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850133.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850134.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850135.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850136.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850137.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001013/GCA_001013785.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001013805.1" alias="A/England/688/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001013805.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/688/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/688/2010 assembly for Influenza A virus (A/England/688/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/688/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645778</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/688/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/688/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295934</PRIMARY_ID>
      <SECONDARY_ID>ERS671536</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN849995.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN849996.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN849997.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN849998.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN849999.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850000.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850001.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850002.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001013/GCA_001013805.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001013825.1" alias="A/England/05100297/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001013825.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/05100297/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/05100297/2010 assembly for Influenza A virus (A/England/05100297/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/05100297/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645793</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/05100297/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/05100297/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295970</PRIMARY_ID>
      <SECONDARY_ID>ERS671561</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850067.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850068.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850069.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850070.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850071.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850072.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850073.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850074.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001013/GCA_001013825.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001013845.1" alias="A/England/687/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001013845.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/687/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/687/2010 assembly for Influenza A virus (A/England/687/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/687/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645789</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/687/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/687/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3298787</PRIMARY_ID>
      <SECONDARY_ID>ERS671548</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850051.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850052.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850053.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850054.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850055.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850056.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850057.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850058.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001013/GCA_001013845.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001013865.1" alias="A/England/10740688/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001013865.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/10740688/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/10740688/2010 assembly for Influenza A virus (A/England/10740688/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/10740688/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645791</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/10740688/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/10740688/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299083</PRIMARY_ID>
      <SECONDARY_ID>ERS671552</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850059.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850060.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850061.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850062.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850063.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850064.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850065.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850066.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001013/GCA_001013865.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001013885.1" alias="A/England/10820733/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001013885.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/10820733/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/10820733/2010 assembly for Influenza A virus (A/England/10820733/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/10820733/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645779</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/10820733/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/10820733/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3298784</PRIMARY_ID>
      <SECONDARY_ID>ERS671539</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850003.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850004.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850005.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850006.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850007.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850008.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850009.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850010.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001013/GCA_001013885.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001013925.1" alias="A/England/717/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001013925.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/717/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/717/2010 assembly for Influenza A virus (A/England/717/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/717/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645797</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/717/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/717/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295972</PRIMARY_ID>
      <SECONDARY_ID>ERS671571</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850091.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850092.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850093.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850094.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850095.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850096.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850097.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850098.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001013/GCA_001013925.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001013945.1" alias="A/England/694/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001013945.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/694/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/694/2010 assembly for Influenza A virus (A/England/694/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/694/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645785</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/694/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/694/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3298781</PRIMARY_ID>
      <SECONDARY_ID>ERS671532</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850035.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850036.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850037.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850038.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850039.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850040.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850041.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850042.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001013/GCA_001013945.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001013965.1" alias="A/England/688/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001013965.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/688/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/688/2010 assembly for Influenza A virus (A/England/688/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/688/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645778</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/688/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/688/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3296957</PRIMARY_ID>
      <SECONDARY_ID>ERS671593</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850281.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850282.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850283.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850284.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850285.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850286.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850287.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850288.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001013/GCA_001013965.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001014005.1" alias="A/England/01180007/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001014005.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/01180007/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/01180007/2010 assembly for Influenza A virus (A/England/01180007/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/01180007/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645818</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/01180007/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/01180007/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294275</PRIMARY_ID>
      <SECONDARY_ID>ERS671621</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850418.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850419.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850420.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850421.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850422.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850423.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850424.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850425.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001014/GCA_001014005.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001014025.1" alias="A/England/692/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001014025.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/692/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/692/2010 assembly for Influenza A virus (A/England/692/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/692/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645812</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/692/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/692/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299524</PRIMARY_ID>
      <SECONDARY_ID>ERS671609</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850305.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850306.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850307.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850308.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850309.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850310.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850311.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850312.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001014/GCA_001014025.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001014045.1" alias="A/England/132/2011" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001014045.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/132/2011</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/132/2011 assembly for Influenza A virus (A/England/132/2011(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/132/2011</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645811</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/132/2011(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/132/2011</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299519</PRIMARY_ID>
      <SECONDARY_ID>ERS671603</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850297.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850298.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850299.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850300.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850301.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850302.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850303.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850304.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001014/GCA_001014045.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001014065.1" alias="A/England/00380709/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001014065.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/00380709/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/00380709/2010 assembly for Influenza A virus (A/England/00380709/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/00380709/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645815</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/00380709/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/00380709/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299525</PRIMARY_ID>
      <SECONDARY_ID>ERS671616</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850334.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850335.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850336.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850337.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850338.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850339.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850340.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850341.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001014/GCA_001014065.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13136</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13136</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001014085.1" alias="A/England/04980053/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001014085.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/04980053/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/04980053/2010 assembly for Influenza A virus (A/England/04980053/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/04980053/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645824</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/04980053/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/04980053/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299528</PRIMARY_ID>
      <SECONDARY_ID>ERS671628</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850716.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850717.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850718.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850719.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850720.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850721.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850722.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850723.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001014/GCA_001014085.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001014105.1" alias="A/England/04900053/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001014105.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/04900053/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/04900053/2010 assembly for Influenza A virus (A/England/04900053/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/04900053/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645817</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/04900053/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/04900053/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299526</PRIMARY_ID>
      <SECONDARY_ID>ERS671620</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850361.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850362.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850363.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850364.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850365.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850366.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850367.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850368.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001014/GCA_001014105.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001014125.1" alias="A/England/11520759/2011" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001014125.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/11520759/2011</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/11520759/2011 assembly for Influenza A virus (A/England/11520759/2011(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/11520759/2011</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645821</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/11520759/2011(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/11520759/2011</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294436</PRIMARY_ID>
      <SECONDARY_ID>ERS671625</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850434.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850435.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850436.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850437.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850438.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850439.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850440.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850441.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001014/GCA_001014125.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001014145.1" alias="A/England/10820734/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001014145.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/10820734/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/10820734/2010 assembly for Influenza A virus (A/England/10820734/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/10820734/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645820</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/10820734/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/10820734/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294435</PRIMARY_ID>
      <SECONDARY_ID>ERS671624</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850426.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850427.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850428.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850429.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850430.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850431.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850432.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850433.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001014/GCA_001014145.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001014165.1" alias="A/England/WTSI1826/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001014165.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/WTSI1826/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/WTSI1826/2010 assembly for Influenza A virus (A/England/WTSI1826/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/WTSI1826/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645809</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/WTSI1826/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/WTSI1826/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294269</PRIMARY_ID>
      <SECONDARY_ID>ERS671601</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850289.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850290.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850291.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850292.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850293.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850294.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850295.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850296.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001014/GCA_001014165.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001014185.1" alias="A/England/10740561/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001014185.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/10740561/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/10740561/2010 assembly for Influenza A virus (A/England/10740561/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/10740561/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645827</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/10740561/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/10740561/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299977</PRIMARY_ID>
      <SECONDARY_ID>ERS671632</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850724.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850725.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850726.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850727.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850728.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850729.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850730.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850731.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001014/GCA_001014185.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001014205.1" alias="A/England/05020673/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001014205.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/05020673/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/05020673/2010 assembly for Influenza A virus (A/England/05020673/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/05020673/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645814</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/05020673/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/05020673/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3293247</PRIMARY_ID>
      <SECONDARY_ID>ERS671612</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850326.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850327.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850328.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850329.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850330.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850331.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850332.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850333.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001014/GCA_001014205.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001014225.1" alias="A/England/01180018/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001014225.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/01180018/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/01180018/2010 assembly for Influenza A virus (A/England/01180018/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/01180018/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645816</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/01180018/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/01180018/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294274</PRIMARY_ID>
      <SECONDARY_ID>ERS671619</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850342.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850343.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850344.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850345.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850346.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850347.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850348.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850349.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001014/GCA_001014225.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001014245.1" alias="A/England/393/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001014245.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/393/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/393/2010 assembly for Influenza A virus (A/England/393/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/393/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645822</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/393/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/393/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299527</PRIMARY_ID>
      <SECONDARY_ID>ERS671626</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850708.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850709.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850710.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850711.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850712.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850713.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850714.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850715.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001014/GCA_001014245.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001014265.1" alias="A/England/377/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001014265.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/377/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/377/2010 assembly for Influenza A virus (A/England/377/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/377/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645813</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/377/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/377/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294271</PRIMARY_ID>
      <SECONDARY_ID>ERS671610</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN850318.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850319.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850320.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850321.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850322.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850323.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850324.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN850325.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001014/GCA_001014265.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-05-27</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001039805.1" alias="A/England/12240612/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001039805.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/12240612/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/12240612/2010 assembly for Influenza A virus (A/England/12240612/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/12240612/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645828</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/12240612/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/12240612/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299978</PRIMARY_ID>
      <SECONDARY_ID>ERS671636</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN866281.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866282.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866283.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866284.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866285.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866286.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866287.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866288.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001039/GCA_001039805.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-06-26</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001039825.1" alias="A/England/10740681/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001039825.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/10740681/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/10740681/2010 assembly for Influenza A virus (A/England/10740681/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/10740681/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645829</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/10740681/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/10740681/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299979</PRIMARY_ID>
      <SECONDARY_ID>ERS671637</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN866298.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866299.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866300.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866301.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866302.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866303.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866304.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866305.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001039/GCA_001039825.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-06-26</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001039845.1" alias="A/England/WTSI2060/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001039845.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/WTSI2060/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/WTSI2060/2010 assembly for Influenza A virus (A/England/WTSI2060/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/WTSI2060/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645831</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/WTSI2060/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/WTSI2060/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299981</PRIMARY_ID>
      <SECONDARY_ID>ERS671639</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN866306.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866307.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866308.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866309.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866310.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866311.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866312.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866313.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001039/GCA_001039845.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-06-26</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001039865.1" alias="A/England/700/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001039865.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/700/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/700/2010 assembly for Influenza A virus (A/England/700/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/700/2010</NAME>
  <ASSEMBLY_LEVEL>chromosome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645832</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/700/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/700/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299982</PRIMARY_ID>
      <SECONDARY_ID>ERS671640</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN866314.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866315.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866316.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866317.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866318.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866319.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866320.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN866321.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001039/GCA_001039865.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13117</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>9</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>1</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-06-26</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001291385.1" alias="A/England/10740581/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001291385.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/10740581/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/10740581/2010 assembly for Influenza A virus (A/England/10740581/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/10740581/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645868</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/10740581/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/10740581/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299517</PRIMARY_ID>
      <SECONDARY_ID>ERS671587</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867491.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867492.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867493.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867494.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867495.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867496.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867497.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867498.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001291/GCA_001291385.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-09-15</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001291405.1" alias="A/England/WTSI1774/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001291405.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/WTSI1774/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/WTSI1774/2010 assembly for Influenza A virus (A/England/WTSI1774/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/WTSI1774/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645848</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/WTSI1774/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/WTSI1774/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3298789</PRIMARY_ID>
      <SECONDARY_ID>ERS671550</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867370.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867371.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867372.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867373.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867374.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867375.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867376.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867377.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001291/GCA_001291405.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-09-15</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_001291425.1" alias="A/England/374/2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_001291425.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A/England/374/2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A/England/374/2010 assembly for Influenza A virus (A/England/374/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A/England/374/2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645840</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/374/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/374/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295974</PRIMARY_ID>
      <SECONDARY_ID>ERS671573</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867881.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867882.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867883.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867884.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867885.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867886.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867887.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867888.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_001/GCA_001291/GCA_001291425.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2015-09-15</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004335.1" alias="A_England_718_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004335.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_718_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_718_2010 assembly for Influenza A virus (A/England/718/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_718_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645881</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/718/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/718/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3293249</PRIMARY_ID>
      <SECONDARY_ID>ERS671614</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867865.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867866.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867867.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867868.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867869.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867870.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867871.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867872.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004335.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004345.1" alias="A_England_672_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004345.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_672_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_672_2010 assembly for Influenza A virus (A/England/672/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_672_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645887</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/672/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/672/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299985</PRIMARY_ID>
      <SECONDARY_ID>ERS671643</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867657.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867658.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867659.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867660.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867661.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867662.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867663.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867664.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004345.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004365.1" alias="A_England_12240614_2011" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004365.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_12240614_2011</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_12240614_2011 assembly for Influenza A virus (A/England/12240614/2011(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_12240614_2011</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645860</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/12240614/2011(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/12240614/2011</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299094</PRIMARY_ID>
      <SECONDARY_ID>ERS671568</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867665.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867666.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867667.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867668.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867669.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867670.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867671.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867672.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004365.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004375.1" alias="A_England_01220741_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004375.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_01220741_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_01220741_2010 assembly for Influenza A virus (A/England/01220741/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_01220741_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645852</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/01220741/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/01220741/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295968</PRIMARY_ID>
      <SECONDARY_ID>ERS671556</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867346.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867347.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867348.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867349.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867350.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867351.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867352.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867353.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004375.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004385.1" alias="A_England_01220639_2009" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004385.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_01220639_2009</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_01220639_2009 assembly for Influenza A virus (A/England/01220639/2009(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_01220639_2009</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645875</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/01220639/2009(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/01220639/2009</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299520</PRIMARY_ID>
      <SECONDARY_ID>ERS671604</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867649.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867650.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867651.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867652.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867653.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867654.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867655.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867656.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004385.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004425.1" alias="A_England_05140281_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004425.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_05140281_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_05140281_2010 assembly for Influenza A virus (A/England/05140281/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_05140281_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645843</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/05140281/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/05140281/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3298782</PRIMARY_ID>
      <SECONDARY_ID>ERS671534</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867338.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867339.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867340.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867341.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867342.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867343.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867344.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867345.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004425.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004435.1" alias="A_England_05080637_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004435.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_05080637_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_05080637_2010 assembly for Influenza A virus (A/England/05080637/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_05080637_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645833</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/05080637/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/05080637/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299983</PRIMARY_ID>
      <SECONDARY_ID>ERS671641</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867633.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867634.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867635.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867636.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867637.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867638.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867639.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867640.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004435.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004445.1" alias="A_England_05100660_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004445.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_05100660_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_05100660_2010 assembly for Influenza A virus (A/England/05100660/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_05100660_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645890</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/05100660/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/05100660/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294444</PRIMARY_ID>
      <SECONDARY_ID>ERS671650</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867737.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867738.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867739.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867740.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867741.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867742.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867743.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867744.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004445.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004455.1" alias="A_England_05140856_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004455.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_05140856_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_05140856_2010 assembly for Influenza A virus (A/England/05140856/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_05140856_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645882</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/05140856/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/05140856/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3293250</PRIMARY_ID>
      <SECONDARY_ID>ERS671615</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867793.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867794.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867795.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867796.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867797.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867798.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867799.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867800.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004455.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004465.1" alias="A_England_WTSI1783_2009" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004465.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_WTSI1783_2009</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_WTSI1783_2009 assembly for Influenza A virus (A/England/WTSI1783/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_WTSI1783_2009</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645855</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/WTSI1783/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/WTSI1783/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295969</PRIMARY_ID>
      <SECONDARY_ID>ERS671559</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867394.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867395.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867396.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867397.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867398.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867399.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867400.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867401.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004465.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13136</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13136</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004475.1" alias="A_England_04980055_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004475.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_04980055_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_04980055_2010 assembly for Influenza A virus (A/England/04980055/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_04980055_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645870</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/04980055/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/04980055/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294262</PRIMARY_ID>
      <SECONDARY_ID>ERS671589</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867499.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867500.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867501.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867502.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867503.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867504.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867505.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867506.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004475.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004485.1" alias="A_England_04980045_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004485.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_04980045_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_04980045_2010 assembly for Influenza A virus (A/England/04980045/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_04980045_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645891</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/04980045/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/04980045/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3300462</PRIMARY_ID>
      <SECONDARY_ID>ERS671654</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867809.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867810.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867811.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867812.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867813.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867814.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867815.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867816.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004485.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004495.1" alias="A_England_10740690_2011" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004495.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_10740690_2011</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_10740690_2011 assembly for Influenza A virus (A/England/10740690/2011(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_10740690_2011</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645889</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/10740690/2011(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/10740690/2011</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294443</PRIMARY_ID>
      <SECONDARY_ID>ERS671649</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867785.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867786.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867787.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867788.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867789.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867790.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867791.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867792.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004495.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004505.1" alias="A_England_414_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004505.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_414_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_414_2010 assembly for Influenza A virus (A/England/414/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_414_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645850</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/414/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/414/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299084</PRIMARY_ID>
      <SECONDARY_ID>ERS671553</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867354.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867355.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867356.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867357.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867358.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867359.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867360.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867361.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004505.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004515.1" alias="A_England_05100301_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004515.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_05100301_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_05100301_2010 assembly for Influenza A virus (A/England/05100301/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_05100301_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645886</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/05100301/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/05100301/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294440</PRIMARY_ID>
      <SECONDARY_ID>ERS671635</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867697.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867698.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867699.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867700.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867701.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867702.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867703.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867704.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004515.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004525.1" alias="A_England_213_2011" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004525.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_213_2011</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_213_2011 assembly for Influenza A virus (A/England/213/2011(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_213_2011</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645838</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/213/2011(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/213/2011</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299990</PRIMARY_ID>
      <SECONDARY_ID>ERS671652</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867729.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867730.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867731.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867732.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867733.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867734.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867735.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867736.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004525.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004535.1" alias="A_England_05140847_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004535.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_05140847_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_05140847_2010 assembly for Influenza A virus (A/England/05140847/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_05140847_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645880</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/05140847/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/05140847/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3293248</PRIMARY_ID>
      <SECONDARY_ID>ERS671613</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867849.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867850.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867851.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867852.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867853.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867854.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867855.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867856.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004535.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004555.1" alias="A_England_689_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004555.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_689_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_689_2010 assembly for Influenza A virus (A/England/689/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_689_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645884</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/689/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/689/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294276</PRIMARY_ID>
      <SECONDARY_ID>ERS671622</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867681.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867682.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867683.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867684.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867685.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867686.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867687.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867688.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004555.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004575.1" alias="A_England_10740623_2011" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004575.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_10740623_2011</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_10740623_2011 assembly for Influenza A virus (A/England/10740623/2011(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_10740623_2011</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645858</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/10740623/2011(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/10740623/2011</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299092</PRIMARY_ID>
      <SECONDARY_ID>ERS671566</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867428.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867429.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867430.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867431.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867432.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867433.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867434.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867435.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004575.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004585.1" alias="A_England_05140177_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004585.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_05140177_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_05140177_2010 assembly for Influenza A virus (A/England/05140177/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_05140177_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645873</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/05140177/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/05140177/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294267</PRIMARY_ID>
      <SECONDARY_ID>ERS671599</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867745.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867746.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867747.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867748.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867749.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867750.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867751.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867752.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004585.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004595.1" alias="A_England_01220740_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004595.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_01220740_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_01220740_2010 assembly for Influenza A virus (A/England/01220740/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_01220740_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645872</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/01220740/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/01220740/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294266</PRIMARY_ID>
      <SECONDARY_ID>ERS671598</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867801.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867802.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867803.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867804.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867805.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867806.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867807.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867808.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004595.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004605.1" alias="A_England_05000088_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004605.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_05000088_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_05000088_2010 assembly for Influenza A virus (A/England/05000088/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_05000088_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1230200</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/05000088/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/05000088/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3298785</PRIMARY_ID>
      <SECONDARY_ID>ERS671541</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867322.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867323.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867324.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867325.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867326.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867327.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867328.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867329.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004605.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004675.1" alias="A_England_01580005_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004675.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_01580005_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_01580005_2010 assembly for Influenza A virus (A/England/01580005/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_01580005_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645847</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/01580005/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/01580005/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295965</PRIMARY_ID>
      <SECONDARY_ID>ERS671547</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867386.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867387.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867388.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867389.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867390.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867391.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867392.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867393.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004675.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004725.1" alias="A_England_10740658_2011" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004725.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_10740658_2011</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_10740658_2011 assembly for Influenza A virus (A/England/10740658/2011(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_10740658_2011</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645861</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/10740658/2011(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/10740658/2011</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295973</PRIMARY_ID>
      <SECONDARY_ID>ERS671572</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867467.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867468.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867469.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867470.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867471.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867472.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867473.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867474.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004725.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004745.1" alias="A_England_05080831_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004745.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_05080831_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_05080831_2010 assembly for Influenza A virus (A/England/05080831/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_05080831_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645859</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/05080831/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/05080831/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299093</PRIMARY_ID>
      <SECONDARY_ID>ERS671567</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867507.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867508.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867509.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867510.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867511.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867512.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867513.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867514.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004745.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004765.1" alias="A_England_01180011_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004765.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_01180011_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_01180011_2010 assembly for Influenza A virus (A/England/01180011/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_01180011_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645893</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/01180011/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/01180011/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3300464</PRIMARY_ID>
      <SECONDARY_ID>ERS671656</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867777.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867778.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867779.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867780.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867781.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867782.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867783.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867784.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004765.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004775.1" alias="A_England_01580003_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004775.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_01580003_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_01580003_2010 assembly for Influenza A virus (A/England/01580003/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_01580003_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645834</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/01580003/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/01580003/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299984</PRIMARY_ID>
      <SECONDARY_ID>ERS671642</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867753.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867754.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867755.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867756.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867757.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867758.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867759.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867760.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004775.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13136</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13136</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004805.1" alias="A_England_WTSI2067_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004805.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_WTSI2067_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_WTSI2067_2010 assembly for Influenza A virus (A/England/WTSI2067/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_WTSI2067_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645836</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/WTSI2067/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/WTSI2067/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299987</PRIMARY_ID>
      <SECONDARY_ID>ERS671646</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867673.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867674.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867675.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867676.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867677.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867678.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867679.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867680.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004805.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004815.1" alias="A_England_04860560_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004815.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_04860560_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_04860560_2010 assembly for Influenza A virus (A/England/04860560/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_04860560_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645862</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/04860560/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/04860560/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295975</PRIMARY_ID>
      <SECONDARY_ID>ERS671577</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867459.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867460.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867461.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867462.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867463.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867464.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867465.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867466.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004815.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004835.1" alias="A_England_665_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004835.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_665_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_665_2010 assembly for Influenza A virus (A/England/665/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_665_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645856</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/665/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/665/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299088</PRIMARY_ID>
      <SECONDARY_ID>ERS671560</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867404.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867405.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867406.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867407.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867408.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867409.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867410.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867411.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004835.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004875.1" alias="A_England_01180015_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004875.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_01180015_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_01180015_2010 assembly for Influenza A virus (A/England/01180015/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_01180015_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645857</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/01180015/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/01180015/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299091</PRIMARY_ID>
      <SECONDARY_ID>ERS671565</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867420.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867421.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867422.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867423.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867424.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867425.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867426.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867427.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004875.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004935.1" alias="A_England_04980653_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004935.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_04980653_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_04980653_2010 assembly for Influenza A virus (A/England/04980653/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_04980653_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645894</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/04980653/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/04980653/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294446</PRIMARY_ID>
      <SECONDARY_ID>ERS671659</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867625.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867626.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867627.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867628.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867629.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867630.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867631.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867632.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004935.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900004945.1" alias="A_England_10740693_2011" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900004945.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_10740693_2011</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_10740693_2011 assembly for Influenza A virus (A/England/10740693/2011(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_10740693_2011</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645867</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/10740693/2011(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/10740693/2011</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295979</PRIMARY_ID>
      <SECONDARY_ID>ERS671586</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867475.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867476.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867477.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867478.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867479.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867480.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867481.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867482.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900004/GCA_900004945.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900005085.1" alias="A_England_690_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900005085.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_690_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_690_2010 assembly for Influenza A virus (A/England/690/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_690_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645849</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/690/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/690/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295966</PRIMARY_ID>
      <SECONDARY_ID>ERS671551</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867330.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867331.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867332.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867333.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867334.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867335.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867336.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867337.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900005/GCA_900005085.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900005115.1" alias="A_England_WTSI1751_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900005115.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_WTSI1751_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_WTSI1751_2010 assembly for Influenza A virus (A/England/WTSI1751/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_WTSI1751_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645842</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/WTSI1751/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/WTSI1751/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3295931</PRIMARY_ID>
      <SECONDARY_ID>ERS671530</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867362.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867363.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867364.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867365.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867366.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867367.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867368.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867369.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900005/GCA_900005115.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900005905.1" alias="A_England_05140176_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900005905.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_05140176_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_05140176_2010 assembly for Influenza A virus (A/England/05140176/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_05140176_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645839</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/05140176/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/05140176/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3300461</PRIMARY_ID>
      <SECONDARY_ID>ERS671653</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867641.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867642.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867643.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867644.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867645.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867646.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867647.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867648.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900005/GCA_900005905.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900005915.1" alias="A_England_05140283_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900005915.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_05140283_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_05140283_2010 assembly for Influenza A virus (A/England/05140283/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_05140283_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645835</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/05140283/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/05140283/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294441</PRIMARY_ID>
      <SECONDARY_ID>ERS671645</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867825.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867826.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867827.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867828.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867829.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867830.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867831.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867832.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900005/GCA_900005915.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900006035.1" alias="A_England_283_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900006035.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_283_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_283_2010 assembly for Influenza A virus (A/England/283/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_283_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645837</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/283/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/283/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299986</PRIMARY_ID>
      <SECONDARY_ID>ERS671644</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867705.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867706.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867707.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867708.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867709.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867710.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867711.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867712.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900006/GCA_900006035.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900006335.1" alias="A_England_686_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900006335.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_686_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_686_2010 assembly for Influenza A virus (A/England/686/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_686_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645878</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/686/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/686/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299523</PRIMARY_ID>
      <SECONDARY_ID>ERS671608</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867689.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867690.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867691.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867692.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867693.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867694.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867695.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867696.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900006/GCA_900006335.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900007775.1" alias="A_England_10740691_2011" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900007775.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_10740691_2011</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_10740691_2011 assembly for Influenza A virus (A/England/10740691/2011(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_10740691_2011</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645879</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/10740691/2011(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/10740691/2011</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3293246</PRIMARY_ID>
      <SECONDARY_ID>ERS671611</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867436.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867437.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867438.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867439.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867440.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867441.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867442.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867443.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900007/GCA_900007775.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900007785.1" alias="A_England_01180017_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900007785.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_01180017_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_01180017_2010 assembly for Influenza A virus (A/England/01180017/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_01180017_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645863</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/01180017/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/01180017/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3296956</PRIMARY_ID>
      <SECONDARY_ID>ERS671578</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867483.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867484.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867485.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867486.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867487.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867488.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867489.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867490.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900007/GCA_900007785.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900009845.1" alias="A_England_WTSI2076_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900009845.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_WTSI2076_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_WTSI2076_2010 assembly for Influenza A virus (A/England/WTSI2076/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_WTSI2076_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645892</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/WTSI2076/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/WTSI2076/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3300463</PRIMARY_ID>
      <SECONDARY_ID>ERS671655</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867817.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867818.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867819.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867820.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867821.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867822.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867823.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867824.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900009/GCA_900009845.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900016655.1" alias="A_England_12240607_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900016655.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_12240607_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_12240607_2010 assembly for Influenza A virus (A/England/12240607/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_12240607_2010</NAME>
  <ASSEMBLY_LEVEL>chromosome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645888</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/12240607/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/12240607/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299988</PRIMARY_ID>
      <SECONDARY_ID>ERS671648</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867761.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867762.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867763.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867764.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867765.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867766.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867767.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867768.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900016/GCA_900016655.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13075</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>9</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>1</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900016665.1" alias="A_England_283_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900016665.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_283_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_283_2010 assembly for Influenza A virus (A/England/283/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_283_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645837</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/283/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/283/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299989</PRIMARY_ID>
      <SECONDARY_ID>ERS671651</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867833.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867834.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867835.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867836.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867837.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867838.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867839.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867840.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900016/GCA_900016665.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900019215.1" alias="A_England_05120013_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900019215.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_05120013_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_05120013_2010 assembly for Influenza A virus (A/England/05120013/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_05120013_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645874</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/05120013/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/05120013/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294268</PRIMARY_ID>
      <SECONDARY_ID>ERS671600</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867873.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867874.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867875.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867876.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867877.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867878.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867879.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867880.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900019/GCA_900019215.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900019225.1" alias="A_England_05140216_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900019225.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_05140216_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_05140216_2010 assembly for Influenza A virus (A/England/05140216/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_05140216_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645876</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/05140216/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/05140216/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299521</PRIMARY_ID>
      <SECONDARY_ID>ERS671606</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867515.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867516.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867517.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867518.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867519.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867520.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867521.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867522.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900019/GCA_900019225.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2018-05-25</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900695505.1" alias="A_England_377_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900695505.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_377_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_377_2010 assembly for Influenza A virus (A/England/377/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_377_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645813</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/377/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/377/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3293239</PRIMARY_ID>
      <SECONDARY_ID>ERS671546</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867378.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867379.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867380.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867381.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867382.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867383.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867384.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867385.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900695/GCA_900695505.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2019-02-21</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900695515.1" alias="A_England_446_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900695515.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_446_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_446_2010 assembly for Influenza A virus (A/England/446/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_446_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645790</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/446/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/446/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294273</PRIMARY_ID>
      <SECONDARY_ID>ERS671618</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867769.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867770.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867771.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867772.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867773.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867774.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867775.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867776.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900695/GCA_900695515.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2019-02-21</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900695525.1" alias="A_England_393_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900695525.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_393_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_393_2010 assembly for Influenza A virus (A/England/393/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_393_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645822</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/393/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/393/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294438</PRIMARY_ID>
      <SECONDARY_ID>ERS671633</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867841.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867842.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867843.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867844.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867845.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867846.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867847.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867848.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900695/GCA_900695525.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2019-02-21</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900695535.1" alias="A_England_331_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900695535.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_331_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_331_2010 assembly for Influenza A virus (A/England/331/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_331_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645782</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/331/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/331/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294439</PRIMARY_ID>
      <SECONDARY_ID>ERS671634</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867713.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867714.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867715.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867716.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867717.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867718.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867719.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867720.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900695/GCA_900695535.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2019-02-21</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900695545.1" alias="A_England_05020673_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900695545.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_05020673_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_05020673_2010 assembly for Influenza A virus (A/England/05020673/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_05020673_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645814</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/05020673/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/05020673/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3294442</PRIMARY_ID>
      <SECONDARY_ID>ERS671647</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867721.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867722.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867723.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867724.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867725.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867726.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867727.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867728.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900695/GCA_900695545.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2019-02-21</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900695555.1" alias="A_England_343_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900695555.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_343_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_343_2010 assembly for Influenza A virus (A/England/343/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_343_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645846</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/343/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/343/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299090</PRIMARY_ID>
      <SECONDARY_ID>ERS671564</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867412.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867413.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867414.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867415.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867416.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867417.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867418.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867419.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900695/GCA_900695555.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2019-02-21</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900695565.1" alias="A_England_10740561_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900695565.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_10740561_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_10740561_2010 assembly for Influenza A virus (A/England/10740561/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_10740561_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645827</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/10740561/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/10740561/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3299096</PRIMARY_ID>
      <SECONDARY_ID>ERS671570</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867451.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867452.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867453.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867454.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867455.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867456.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867457.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867458.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900695/GCA_900695565.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2019-02-21</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
<ASSEMBLY accession="GCA_900695575.1" alias="A_England_374_2010" center_name="SC">
  <IDENTIFIERS>
    <PRIMARY_ID>GCA_900695575.1</PRIMARY_ID>
    <SUBMITTER_ID namespace="SC">A_England_374_2010</SUBMITTER_ID>
  </IDENTIFIERS>
  <TITLE>A_England_374_2010 assembly for Influenza A virus (A/England/374/2010(H1N1))</TITLE>
  <DESCRIPTION>The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission. In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011. Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time. Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus. In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor. However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs. NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses. Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells. Mutations in HA and NA genes in third-wave viruses caused increased binding to α-2,6-sialic acid and enhanced infectivity in human mucus. A recombinant virus with these two segments replicated more efficiently in HAE cells. A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells. Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.&lt;/p&gt;</DESCRIPTION>
  <NAME>A_England_374_2010</NAME>
  <ASSEMBLY_LEVEL>complete genome</ASSEMBLY_LEVEL>
  <GENOME_REPRESENTATION>full</GENOME_REPRESENTATION>
  <TAXON>
    <TAXON_ID>1645840</TAXON_ID>
    <SCIENTIFIC_NAME>Influenza A virus (A/England/374/2010(H1N1))</SCIENTIFIC_NAME>
    <STRAIN>A/England/374/2010</STRAIN>
  </TAXON>
  <SAMPLE_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>SAMEA3300465</PRIMARY_ID>
      <SECONDARY_ID>ERS671657</SECONDARY_ID>
    </IDENTIFIERS>
  </SAMPLE_REF>
  <STUDY_REF>
    <IDENTIFIERS>
      <PRIMARY_ID>PRJEB8717</PRIMARY_ID>
    </IDENTIFIERS>
  </STUDY_REF>
  <CHROMOSOMES>
    <CHROMOSOME accession="LN867857.1">
      <NAME>1</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867858.1">
      <NAME>2</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867859.1">
      <NAME>3</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867860.1">
      <NAME>4</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867861.1">
      <NAME>5</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867862.1">
      <NAME>6</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867863.1">
      <NAME>7</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
    <CHROMOSOME accession="LN867864.1">
      <NAME>8</NAME>
      <TYPE>Segment</TYPE>
    </CHROMOSOME>
  </CHROMOSOMES>
  <ASSEMBLY_LINKS>
    <ASSEMBLY_LINK>
      <URL_LINK>
        <LABEL>Sequence Report</LABEL>
        <URL>ftp://ftp.ebi.ac.uk/pub/databases/ena/assembly/GCA_900/GCA_900695/GCA_900695575.1_sequence_report.txt</URL>
      </URL_LINK>
    </ASSEMBLY_LINK>
  </ASSEMBLY_LINKS>
  <ASSEMBLY_ATTRIBUTES>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>total-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ungapped-length</TAG>
      <VALUE>13133</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>scaffold-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>replicon-count</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-non-chromosome-replicon</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-contig</TAG>
      <VALUE>8</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>count-regions</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>spanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>unspanned-gaps</TAG>
      <VALUE>0</VALUE>
    </ASSEMBLY_ATTRIBUTE>
    <ASSEMBLY_ATTRIBUTE>
      <TAG>ENA-LAST-UPDATED</TAG>
      <VALUE>2019-02-21</VALUE>
    </ASSEMBLY_ATTRIBUTE>
  </ASSEMBLY_ATTRIBUTES>
</ASSEMBLY>
</ASSEMBLY_SET>
